• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Home | Biochemicals | Cancer Biology | Anticancer | Tyrosine Kinase Inhibitors | c-kit

c-kit

Product ID
Name
Description
Purity
  • D0375

    Dasatinib Monohydrate

    Abl, PDGFR, EphR, Src, k-Kit, FYN, LCK, HCK inhibi...
    ≥98%
  • M0374

    Masitinib

    PDGFR and c-Kit inhibitor.
    ≥98%
  • M5876

    Motesanib

    VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
    ≥98%
  • M5877

    Motesanib Diphosphate

    VEGFR, PDGFR, c-Kit, RET inhibitor.
    ≥98%
  • N3346

    Nilotinib

    Phenylamino pyridine; Abl, c-Kit, PDGFR, PP2A inhi...
    ≥98%
  • P0397

    Pazopanib

    VEGFR, PDGFR, c-Kit inhibitor.
    ≥97%
  • Q8139

    Quizartinib

    FLT3, c-Kit, PDGFR inhibitor.
    ≥98%
  • R0020

    RAF265

    B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit, S...
    ≥98%
  • R1626

    Regorafenib Monohydrate

    VEGFR1/2/3, TIE2, PDGFRβ, FGFR1, c-Kit, RET, B-Ra...
    ≥99%
  • T0152

    Tandutinib

    FLT3, PDGFR, c-Kit inhibitor.
    ≥98%
  • T3585

    Tivozanib

    VEGFR1/2/3, c-Kit, PDGFR inhibitor.
    ≥98%

Showing all 11 results

sidebar

Store Sidebar

Product Categories

  • Biochemicals (2187)
    • Cancer Biology (972)
      • Anti-angiogenic (144)
      • Anti-metastatic (56)
      • Anticancer (797)
        • Anti-mitotics (46)
        • Compounds targeting DNA synthesis and repair (58)
        • DNA Crosslinking and Alkylating Agents (16)
        • Epigenetic Modifiers (33)
        • Hormone Receptor Modulators (24)
        • Inhibitors of other enzymes (48)
        • Nucleoside and Nucleotide Analogs (18)
        • Serine/Threonine Kinase Inhibitors (140)
        • Transcription Factor Modifiers (63)
        • Tyrosine Kinase Inhibitors (101)
          • Abl (11)
          • ALK (11)
          • Axl (3)
          • BTK (3)
          • c-kit (11)
          • c-met (9)
          • EGFR (26)
          • ephR (1)
          • FGFR (5)
          • FLT (8)
          • FYN (1)
          • IGF-1R (8)
          • JAK (12)
          • PDGFR (18)
          • RET (8)
          • Ron (4)
          • ROS1 (3)
          • src (8)
          • TIE (2)
          • VEGFR (20)
      • Antioxidant (248)
      • Carcinogens and Mutagens (30)
      • Chemopreventive (102)
    • Cardiovascular (324)
    • Endocrine Signaling and Immunology (783)
    • Metabolic and GI Pathology (278)
    • Microbiology (443)
    • Natural Products (530)
    • Neuroscience (539)
    • Peptides (540)
    • Pharmaceutical Impurities and Derivatives (1)
    • Stem Cell Modulators (12)
  • New Products (150)
  • Other Products (219)
  • Uncategorized (751)

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only